Table 1 Demographics of study subjects.
From: Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis
| Â | Cases (N) | (%) | Controls (N) | (%) |
|---|---|---|---|---|
Total | 205 | 64% | 115 | 36% |
Diagnosis | ||||
  Schizophrenia | 118 | 58% | – | – |
  Bipolar Disorder | 48 | 23% | – | – |
  Schizoaffective Disorder | 39 | 19% | – | – |
Race | ||||
  African American/Black | 28 | 14% | 7 | 6% |
  American Indian/Alaskan Native | 2 | 1% | 0 | 0% |
  Asian | 15 | 7% | 27 | 23% |
  Caucasian/White | 131 | 64% | 61 | 53% |
  Native Hawaiian/Pacific Islander | 3 | 1% | 1 | 1% |
  Multiple or unknown | 26 | 13% | 19 | 17% |
Ethnicity | ||||
  Hispanic/Latino | 50 | 24% | 17 | 15% |
  Non-Hispanic/Latino | 151 | 74% | 97 | 84% |
  Unknown | 4 | 2% | 1 | 1% |
Inferred 1000 Genomes superpopulation | ||||
  African (AFR) | 58 | 28% | 19 | 17% |
  American (AMR) | 20 | 10% | 8 | 7% |
  East Asian (EAS) | 14 | 7% | 26 | 23% |
  European (EUR) | 110 | 54% | 53 | 46% |
  South Asian (SAS) | 3 | 1% | 9 | 8% |
Sex | ||||
  Male | 158 | 77% | 67 | 58% |
  Female | 47 | 23% | 48 | 42% |
Mean age (s.d.) | 19.7 (4.1) | Â | 19.7 (4.2) | Â |
